AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory, Vaccines & Immunology.
Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. In Serbia the company is present for 45 years. In 2021, the Balkan Cluster was created, which includes Serbia, Bulgaria, Croatia, Slovenia and Montenegro. As of 2022 the group approved a project, thanks to which AstraZeneca enters through a partner the countries in the Southern Balkans: Bosnia and Herzegovina, North Macedonia, Albania and Kosovo.
Currently more than 250 professionals work in AstraZeneca Balkans, and by 2025 the team will reach over 350 people. As a pharmaceutical industry leader committed to support people have longer and healthier lives, social responsibility is part of company’s philosophy and DNA. Its ambitious sustainable agenda is focused in 3 main directions: access to healthcare, environmental protection, ethics and transparency.
Visit their website: https://www.astrazeneca.com/country-sites/serbia.html